• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学品监管风险评估中效应生物标志物使用指南制定的概念基础。

Conceptual basis for the development of guidance for the use of biomarkers of effect in regulatory risk assessment of chemicals.

作者信息

Hernández-Jerez Antonio, Hougaard Bennekou Susanne, Hoogenboom Laurentius Ron, Mcardle Henry, Pieper Christina, Schwerdtle Tanja, Van Loveren Hendrik, Al Harraq Zainab, Croera Cristina, Christodoulidou Anna, De Sesmaisons Agnès, Eskes Chantra, Levorato Sara, Valtueña Martínez Silvia, Bompola Georgia, Farcal Lucian

出版信息

EFSA J. 2024 Dec 17;22(12):e9153. doi: 10.2903/j.efsa.2024.9153. eCollection 2024 Dec.

DOI:10.2903/j.efsa.2024.9153
PMID:39691503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11650060/
Abstract

This Scientific Report was carried out in the context of the self-task mandate (M-2023-00097) of the EFSA's Scientific Committee on 'Guidance on the use of biomarkers of effect in regulatory risk assessment of chemicals'. In the first phase, the project on biomarkers of effect started with a feasibility study (EFSA-Q-2024-00128), with the intention to look closer at definitions and descriptions of biomarkers of effect, as well as to explore several concepts related to the context of application and other scientific principles to be further considered for its development. In addition, relevant activities, initiatives and knowledge in this area were collected and analysed within a complementary mapping study. The outcome of this phase aimed to create a structured basis for future guidance, to identify challenges and to recommend a way forward for its development. The recommendations refer especially to terminologies, the scope of the guidance and several scientific and technical aspects of the selection and interpretation of biomarkers of effect that need to be addressed in future guidance. Moreover, further recommendation refers to the collaborative process to be established with other regulatory organisations that should support the harmonisation and reduce divergencies in the application of methodologies across organisations or sectors.

摘要

本科学报告是在欧洲食品安全局(EFSA)科学委员会关于“化学物质监管风险评估中效应生物标志物使用指南”的自主任务授权(M - 2023 - 00097)背景下开展的。在第一阶段,效应生物标志物项目始于一项可行性研究(EFSA - Q - 2024 - 00128),旨在更深入地研究效应生物标志物的定义和描述,并探讨与应用背景相关的几个概念以及其发展中需进一步考虑的其他科学原则。此外,在一项补充性映射研究中收集并分析了该领域的相关活动、倡议和知识。此阶段的成果旨在为未来指南创建结构化基础,识别挑战并为其发展推荐前进方向。这些建议尤其涉及术语、指南范围以及效应生物标志物选择和解释的若干科学技术方面,这些在未来指南中都需要加以解决。此外,进一步的建议涉及与其他监管组织建立协作流程,这应有助于实现方法应用在各组织或部门间的协调统一并减少差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11650060/b90b0c0667c2/EFS2-22-e9153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11650060/e35fc49705ba/EFS2-22-e9153-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11650060/454fa0529884/EFS2-22-e9153-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11650060/b90b0c0667c2/EFS2-22-e9153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11650060/e35fc49705ba/EFS2-22-e9153-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11650060/454fa0529884/EFS2-22-e9153-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11650060/b90b0c0667c2/EFS2-22-e9153-g001.jpg

相似文献

1
Conceptual basis for the development of guidance for the use of biomarkers of effect in regulatory risk assessment of chemicals.化学品监管风险评估中效应生物标志物使用指南制定的概念基础。
EFSA J. 2024 Dec 17;22(12):e9153. doi: 10.2903/j.efsa.2024.9153. eCollection 2024 Dec.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
The principles and methods behind EFSA's Guidance on Uncertainty Analysis in Scientific Assessment.欧洲食品安全局科学评估中不确定性分析指南背后的原则和方法。
EFSA J. 2018 Jan 24;16(1):e05122. doi: 10.2903/j.efsa.2018.5122. eCollection 2018 Jan.
4
Scientific motivations and criteria to consider updating EFSA scientific assessments.考虑更新欧洲食品安全局科学评估的科学动机和标准。
EFSA J. 2017 Mar 17;15(3):e04737. doi: 10.2903/j.efsa.2017.4737. eCollection 2017 Mar.
5
Draft for internal testing Scientific Committee guidance on appraising and integrating evidence from epidemiological studies for use in EFSA's scientific assessments.内部测试草案 科学委员会关于评估和整合流行病学研究证据以供欧洲食品安全局科学评估使用的指南。
EFSA J. 2020 Aug 18;18(8):e06221. doi: 10.2903/j.efsa.2020.6221. eCollection 2020 Aug.
6
Translating data into policy informing decisions: current and future perspectives from the European Food Safety Authority (EFSA).将数据转化为为决策提供信息的政策:来自欧洲食品安全局(EFSA)的当前及未来观点。
Proc Nutr Soc. 2025 Feb 5:1-9. doi: 10.1017/S0029665125000047.
7
Scientific Committee guidance on appraising and integrating evidence from epidemiological studies for use in EFSA's scientific assessments.科学委员会关于评估和整合流行病学研究证据以供欧洲食品安全局科学评估使用的指南。
EFSA J. 2024 Jul 5;22(7):e8866. doi: 10.2903/j.efsa.2024.8866. eCollection 2024 Jul.
8
Risk Assessment of Combined Exposure to Multiple Chemicals at the European Food Safety Authority: Principles, Guidance Documents, Applications and Future Challenges.欧洲食品安全局对多种化学物质联合暴露风险评估:原则、指导文件、应用及未来挑战。
Toxins (Basel). 2023 Jan 4;15(1):40. doi: 10.3390/toxins15010040.
9
Guidance on protocol development for EFSA generic scientific assessments.欧洲食品安全局通用科学评估方案制定指南。
EFSA J. 2023 Oct 30;21(10):e08312. doi: 10.2903/j.efsa.2023.8312. eCollection 2023 Oct.
10
EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead.欧洲食品安全局成立头十年在转基因生物风险评估方面的科学活动与成果:回顾与展望。
Transgenic Res. 2014 Feb;23(1):1-25. doi: 10.1007/s11248-013-9741-4. Epub 2013 Aug 21.

引用本文的文献

1
Molecular response of to antibiotics.(此处“of”后缺少具体内容)对抗生素的分子反应。
Curr Res Toxicol. 2025 May 18;8:100239. doi: 10.1016/j.crtox.2025.100239. eCollection 2025.

本文引用的文献

1
Guidance on risk-benefit assessment of foods.食品风险效益评估指南。
EFSA J. 2024 Jul 16;22(7):e8875. doi: 10.2903/j.efsa.2024.8875. eCollection 2024 Jul.
2
Scientific Committee guidance on appraising and integrating evidence from epidemiological studies for use in EFSA's scientific assessments.科学委员会关于评估和整合流行病学研究证据以供欧洲食品安全局科学评估使用的指南。
EFSA J. 2024 Jul 5;22(7):e8866. doi: 10.2903/j.efsa.2024.8866. eCollection 2024 Jul.
3
OECD harmonised template 201: Structuring and reporting mechanistic information to foster the integration of new approach methodologies for hazard and risk assessment of chemicals.
OECD 协调模板 201:构建和报告机制信息,以促进将新方法学整合用于化学品危害和风险评估。
Regul Toxicol Pharmacol. 2023 Aug;142:105426. doi: 10.1016/j.yrtph.2023.105426. Epub 2023 Jun 3.
4
Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge.人类生物监测研究中效应生物标志物的应用:一种整合毒理学和流行病学知识的系统方法。
Int J Hyg Environ Health. 2023 Apr;249:114140. doi: 10.1016/j.ijheh.2023.114140. Epub 2023 Feb 24.
5
Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases.生物标志物:用于新冠病毒病及其他疾病诊断、预后评估和治疗的有前景且有价值的工具。
Heliyon. 2023 Feb;9(2):e13323. doi: 10.1016/j.heliyon.2023.e13323. Epub 2023 Jan 30.
6
Guidance on the use of the benchmark dose approach in risk assessment.风险评估中基准剂量法的使用指南。
EFSA J. 2022 Oct 25;20(10):e07584. doi: 10.2903/j.efsa.2022.7584. eCollection 2022 Oct.
7
When I use a word . . . . Too much healthcare-Biomarkers.
BMJ. 2022 Oct 21;379:o2533. doi: 10.1136/bmj.o2533.
8
From Qualitative to Quantitative AOP: A Case Study of Neurodegeneration.从定性到定量的不良结局途径:神经退行性变的案例研究
Front Toxicol. 2022 Mar 30;4:838729. doi: 10.3389/ftox.2022.838729. eCollection 2022.
9
Guidance for establishing and applying tolerable upper intake levels for vitamins and essential minerals: Draft for internal testing.维生素和必需矿物质可耐受最高摄入量设定与应用指南:内部测试草案
EFSA J. 2022 Jan 24;20(1):e200102. doi: 10.2903/j.efsa.2022.e200102. eCollection 2022 Jan.
10
Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients.为将下一代风险评估应用于化妆品成分的安全决策铺平道路。
Regul Toxicol Pharmacol. 2021 Oct;125:105026. doi: 10.1016/j.yrtph.2021.105026. Epub 2021 Aug 10.